Cargando…
Stem cells and cancer immunotherapy: Arrowhead’s 2(nd) annual cancer immunotherapy conference
Investigators from academia and industry gathered on April 4 and 5, 2013, in Washington DC at the Arrowhead’s 2(nd) Annual Cancer Immunotherapy Conference. Two complementary concepts were discussed: cancer “stem cells” as targets and therapeutic platforms based on stem cells.
Autores principales: | Bot, Adrian, Chiriva-Internati, Maurizio, Cornforth, Andrew, Czerniecki, Brian J, Ferrone, Soldano, Geles, Kenneth, Greenberg, Philip D, Hurt, Elaine, Koya, Richard C, Manjili, Masoud H, Matsui, William, Morgan, Richard A, Palena, Claudia M, Powell Jr , Daniel J, Restifo, Nicholas P, Spencer, David M, Vizcardo, Raul, Wong, Albert J, Yang, Lili, Yu, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019892/ http://dx.doi.org/10.1186/2051-1426-2-6 |
Ejemplares similares
-
Cancer immunotherapy: avoiding the road to perdition
por: Chiriva-Internati, Maurizio, et al.
Publicado: (2004) -
High frequency of HLA class I antigen processing machinery (APM) component upregulation in primary hepatocellular carcinoma tumors
por: Grizzi, Fabio, et al.
Publicado: (2013) -
The premise of personalized immunotherapy for cancer dormancy: Cancer dormancy vaccines
por: Manjili, Masoud H.
Publicado: (2020) -
CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
por: Maggs, Luke, et al.
Publicado: (2021) -
Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems
por: Manjili, Masoud H., et al.
Publicado: (2012)